(Q42198454)

English

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Michael Pawlita

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Christine C Roberts

object named as

Christine Roberts

9

0 references

author name string

Darron Brown

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Martin Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Peter Sehr

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Hanna Seitz

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Ivonne Rubio

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Joseph Antonello

7

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

David Radley

8

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Alfred Saah

10

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

language of work or name

0 references

publication date

19 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

5880-5887

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Multiplexed serologic assay for nine anogenital human papillomavirus types

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.08.004

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.08.004

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42198454&oldid=1967180241"